Amiloidózis: vizsgálatok itt: Portugália

In Portugália 14 Also abroad 184

14 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Where
Lisbon
Életkor
18 év to 90 év
People
1200 worldwide
Run by
Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00
3. fázisCsak meghívásos
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Creixomil, Lisbon, Porto, Viseu
Életkor
18 év and over
People
700 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT06679946
3. fázisTaking people
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Carnaxide, Guimaraes, Leiria, Lisbon, Vila Real, Viseu
Életkor
18 év to 85 év
People
1750 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00
No phaseTaking people
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Where
Lisbon, Porto
People
1500 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT04561518
No phaseTaking people
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Where
Lisbon
People
10 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT05040373
3. fázisTaking people
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Where
Lisboa, Porto
Életkor
18 év to 85 év
People
125 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07223203 · EU 2025-522544-40-00
No phaseTaking people
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Where
Multiple Locations
Életkor
18 év and over
People
2000 worldwide
Run by
Bayer
See details and how to joinNCT07235462
No phaseTaking people
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Where
Lisbon, Porto
People
52 121 worldwide
Run by
AstraZeneca
See details and how to joinNCT06355934
No phaseTaking people
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
Where
Guimarães, Lisbon
Életkor
18 év and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07690436
3. fázisNot yet taking people in Portugália
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Where
Lisbon, Porto
Életkor
18 év and over
People
250 worldwide
Run by
Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT07116473 · EU 2024-513676-18-00
3. fázisTaking people
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Where
Lisbon, Porto
Életkor
18 év to 75 év
People
587 worldwide
Run by
Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT06563895 · EU 2024-513547-82-00
3. fázisCsak meghívásos
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Where
Guimarães, Lisbon, Porto
Életkor
18 év and over
People
1400 worldwide
Run by
Ionis Pharmaceuticals, Inc.
See details and how to joinNCT05667493
No phaseTaking people
Exercise in Hereditary ATTR (ATTRv) Amyloidosis
Where
Maia
Életkor
18 év and over
People
42
Run by
University of Maia
See details and how to joinNCT07033715
No phaseTaking people
International Cardiac Amyloidosis Registry
Where
Lisbon
Életkor
18 év and over
People
300 worldwide
Run by
Leiden University Medical Center
See details and how to joinNCT06894290